Suppr超能文献

慢性肾脏病进展的危险因素。

Risk factors for progression of chronic kidney disease.

机构信息

Division of Pediatric Nephrology, Department of Pediatrics, University of New Mexico, Children's Hospital, Albuquerque, New Mexico, USA.

出版信息

Curr Opin Pediatr. 2010 Apr;22(2):161-9. doi: 10.1097/MOP.0b013e328336ebb0.

Abstract

PURPOSE OF REVIEW

The present review provides an overview of the identified risk factors for chronic kidney disease (CKD) progression emphasizing the pediatric population.

RECENT FINDINGS

Over the past 10 years, there have been significant changes to our understanding and study of preterminal kidney failure. Recent refinements in the measurement of glomerular filtration rate and glomerular filtration rate estimating equations are important tools for identification and association of risk factors for CKD progression in children. In pediatric CKD, lower level of kidney function at presentation, higher levels of proteinuria, and hypertension are known markers for a more rapid decline in glomerular filtration rate. Anemia and other reported risk factors from the pregenomic era require further study and validation. Genome-wide association studies have identified genetic loci that have provided novel genetic risk factors for CKD progression.

SUMMARY

With cohort studies of children with CKD becoming mature, they have started to yield important refinements to the assessment of CKD progression. Although many of the traditional risk factors for renal progression will certainly be assessed, such cohorts will be important for evaluating novel risk factors identified by genome-wide studies.

摘要

目的综述

本文重点介绍了儿科人群慢性肾脏病(CKD)进展的相关风险因素,并对其进行了概述。

最近发现

在过去的 10 年中,我们对终末期肾衰竭的认识和研究发生了重大变化。肾小球滤过率的测量和肾小球滤过率估算方程的最新改进是识别和关联儿童 CKD 进展风险因素的重要工具。在儿科 CKD 中,起病时肾功能水平较低、蛋白尿水平较高和高血压是肾小球滤过率快速下降的已知标志物。贫血和前基因组时代报告的其他风险因素需要进一步研究和验证。全基因组关联研究已经确定了与 CKD 进展相关的新的遗传风险因素。

总结

随着针对 CKD 患儿的队列研究逐渐成熟,它们开始对 CKD 进展的评估进行重要的细化。虽然肯定会评估许多传统的肾脏进展风险因素,但这些队列对于评估全基因组研究确定的新风险因素非常重要。

相似文献

1
Risk factors for progression of chronic kidney disease.
Curr Opin Pediatr. 2010 Apr;22(2):161-9. doi: 10.1097/MOP.0b013e328336ebb0.
4
Estimating Time to ESRD in Children With CKD.
Am J Kidney Dis. 2018 Jun;71(6):783-792. doi: 10.1053/j.ajkd.2017.12.011. Epub 2018 Apr 10.
5
The CKiD study: overview and summary of findings related to kidney disease progression.
Pediatr Nephrol. 2021 Mar;36(3):527-538. doi: 10.1007/s00467-019-04458-6. Epub 2020 Feb 3.
7
Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
Am J Kidney Dis. 2020 Aug;76(2):194-202. doi: 10.1053/j.ajkd.2019.11.004. Epub 2020 Jan 24.
8
Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
Clin J Am Soc Nephrol. 2023 Feb 1;18(2):173-182. doi: 10.2215/CJN.0000000000000051. Epub 2023 Jan 18.
10
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies.
Pediatr Nephrol. 2022 Jun;37(6):1215-1229. doi: 10.1007/s00467-021-05145-1. Epub 2021 Jun 6.

引用本文的文献

2
Polygenic risk scores for eGFR are associated with age at kidney failure.
J Nephrol. 2025 Apr;38(3):969-978. doi: 10.1007/s40620-025-02207-7. Epub 2025 Mar 3.
4
Association of serum 25-hydroxyvitamin D with cardiovascular mortality and kidney outcome in patients with early stages of CKD.
J Endocrinol Invest. 2024 Nov;47(11):2745-2755. doi: 10.1007/s40618-024-02383-6. Epub 2024 May 11.
6
SGLT2 inhibitors: Beyond glycemic control.
J Clin Transl Endocrinol. 2024 Mar 12;35:100335. doi: 10.1016/j.jcte.2024.100335. eCollection 2024 Mar.
7
The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.
Int J Environ Res Public Health. 2022 Aug 11;19(16):9878. doi: 10.3390/ijerph19169878.
9
Association of morning blood pressure surge with chronic kidney disease progression in patients with chronic kidney disease and hypertension.
J Clin Hypertens (Greenwich). 2021 Oct;23(10):1879-1886. doi: 10.1111/jch.14366. Epub 2021 Sep 9.

本文引用的文献

1
Strict blood-pressure control and progression of renal failure in children.
N Engl J Med. 2009 Oct 22;361(17):1639-50. doi: 10.1056/NEJMoa0902066.
2
Longitudinal formulas to estimate GFR in children with CKD.
Clin J Am Soc Nephrol. 2009 Nov;4(11):1724-30. doi: 10.2215/CJN.01860309. Epub 2009 Sep 17.
3
Uric acid: a novel mediator and marker of risk in chronic kidney disease?
Curr Opin Nephrol Hypertens. 2009 Nov;18(6):526-30. doi: 10.1097/MNH.0b013e328330d9d0.
4
Bicarbonate supplementation slows progression of CKD and improves nutritional status.
J Am Soc Nephrol. 2009 Sep;20(9):2075-84. doi: 10.1681/ASN.2008111205. Epub 2009 Jul 16.
5
Renal outcome in patients with congenital anomalies of the kidney and urinary tract.
Kidney Int. 2009 Sep;76(5):528-33. doi: 10.1038/ki.2009.220. Epub 2009 Jun 17.
6
Multiple loci associated with indices of renal function and chronic kidney disease.
Nat Genet. 2009 Jun;41(6):712-7. doi: 10.1038/ng.377. Epub 2009 May 10.
7
Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.
Pediatr Nephrol. 2009 Dec;24(12):2309-19. doi: 10.1007/s00467-009-1199-5. Epub 2009 May 7.
8
Genome-wide linkage analysis of serum creatinine in three isolated European populations.
Kidney Int. 2009 Aug;76(3):297-306. doi: 10.1038/ki.2009.135. Epub 2009 Apr 22.
9
Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.
J Am Soc Nephrol. 2009 May;20(5):961-8. doi: 10.1681/ASN.2008060613. Epub 2009 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验